157 related articles for article (PubMed ID: 17970647)
21. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
[TBL] [Abstract][Full Text] [Related]
22. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
Yamamoto Y; Ono T; Dhar DK; Yamanoi A; Tachibana M; Tanaka T; Nagasue N
J Gastroenterol Hepatol; 2008 Jun; 23(6):930-7. PubMed ID: 18565023
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells.
Arnold R; König W
Virology; 2006 Mar; 346(2):427-39. PubMed ID: 16330064
[TBL] [Abstract][Full Text] [Related]
24. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
[TBL] [Abstract][Full Text] [Related]
25. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
26. The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages.
Amoruso A; Bardelli C; Fresu LG; Poletti E; Palma A; Federici Canova D; Zeng HW; Ongini E; Brunelleschi S
Pharmacol Res; 2010 Nov; 62(5):391-9. PubMed ID: 20670683
[TBL] [Abstract][Full Text] [Related]
27. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
[TBL] [Abstract][Full Text] [Related]
28. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
Yuan J; Takahashi A; Masumori N; Uchida K; Hisasue S; Kitamura H; Itoh N; Tsukamoto T
Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
[TBL] [Abstract][Full Text] [Related]
29. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease.
Rajendrasozhan S; Yang SR; Kinnula VL; Rahman I
Am J Respir Crit Care Med; 2008 Apr; 177(8):861-70. PubMed ID: 18174544
[TBL] [Abstract][Full Text] [Related]
30. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Belvisi MG; Hele DJ; Birrell MA
Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
[TBL] [Abstract][Full Text] [Related]
33. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
Coyle AT; Kinsella BT
Biochem Pharmacol; 2006 Apr; 71(9):1308-23. PubMed ID: 16499875
[TBL] [Abstract][Full Text] [Related]
34. Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats.
García-Bueno B; Caso JR; Pérez-Nievas BG; Lorenzo P; Leza JC
Neuropsychopharmacology; 2007 Jun; 32(6):1251-60. PubMed ID: 17119541
[TBL] [Abstract][Full Text] [Related]
35. Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma.
Soares AF; Nosjean O; Cozzone D; D'Orazio D; Becchi M; Guichardant M; Ferry G; Boutin JA; Lagarde M; Géloën A
Biochem Biophys Res Commun; 2005 Nov; 337(2):521-5. PubMed ID: 16198309
[TBL] [Abstract][Full Text] [Related]
36. PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase.
Verrier E; Wang L; Wadham C; Albanese N; Hahn C; Gamble JR; Chatterjee VK; Vadas MA; Xia P
Circ Res; 2004 Jun; 94(11):1515-22. PubMed ID: 15117825
[TBL] [Abstract][Full Text] [Related]
37. HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomas.
Théoleyre S; Mottier S; Masson D; Denis MG
Biochem Biophys Res Commun; 2010 Apr; 394(3):453-8. PubMed ID: 19951697
[TBL] [Abstract][Full Text] [Related]
38. Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growth.
Pon CK; Firth SM; Baxter RC
Mol Cell Endocrinol; 2015 Jan; 399():354-61. PubMed ID: 25449421
[TBL] [Abstract][Full Text] [Related]
39. 15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism.
Willermain F; Dulku S; Gonzalez NS; Blero D; Driessens G; De Graef C; Caspers L; Bruyns C
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):136-43. PubMed ID: 16939878
[TBL] [Abstract][Full Text] [Related]
40. Erythromycin inhibits cigarette smoke-induced inflammation through regulating the PPARγ/NF-κB signaling pathway in macrophages.
Qiu JF; Ma N; He ZY; Zhong XN; Zhang JQ; Bai J; Deng JM; Tang XJ; Luo ZL; Huang M; Liang Q; Wei YL; Tang MJ; Li MH
Int Immunopharmacol; 2021 Jul; 96():107775. PubMed ID: 34162143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]